A review in the Canadian Journal of Physiology and Pharmacology examines emerging evidence linking glucagon-like peptide-1 receptor agonists (GLP-1 RAs), the gut microbiome, and obesity treatment ...
The weight-loss drugs market is set to grow to around Rs 5,000 crore in India by 2030, up from Rs 1,000 crore at present, ...
GLP-1 medications are widely used for weight loss and diabetes management. But these drugs may lead to vitamin or mineral deficiencies. Know how.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results